Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 USD | +1.43% | +5.97% | -47.41% |
Jun. 30 | Enlivex Therapeutics Ltd.'s Equity Buyback announced on August 30, 2023 has expired. | CI |
Jun. 24 | Enlivex Therapeutics Says First Patient Dosed in Phase 1/2 Thumb Osteoarthritis Trial | MT |
- Stock Market
- Equities
- ENLV Stock
- News Enlivex Therapeutics Ltd.
- MarketScreener Strategies